£1.4M
The funding round was co-led by DSW Ventures and NG Bio alongside a grant from Innovate UK.
£1.4MTotal raised
Mesenbio is a University of York spin-out developing engineered stem-cell treatments for inflammatory conditions.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Mesenbio's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
PG
Paul Genever
Professor
DK
David Kuntin
CEO